Course Provider
Learning Objectives
a. Identify patients eligible for FDA approved disease modifying treatments.
b. List all FDA approved treatment options available for patients with AD and related dementias.
c. Identify NIA-AA updated criteria for a diagnostic evaluation for dementia.
d. Discuss new treatments in research.
1.Apply design thinking principles to anticipate and adapt to changes in Care Manager roles within an AI-enhanced healthcare environment.
2.Discuss strategies to influence the ethical and practical development of future Care Technologies to benefit older adults.
3.Evaluate the impact of emerging care technologies on patient engagement, communication, and care coordination, ensuring adherence to ethical standards and improving quality of care.